Lexical Priming by Music in Alzheimer's Disease and Healthy Aging (PriMus)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03342326 |
|
Recruitment Status :
Terminated
(failure to recruit)
First Posted : November 14, 2017
Last Update Posted : September 11, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Alzheimer Disease | Other: Exposure to familiar songs Other: Music Experience Questionnaire Other: Implicit tasks memory Other: Questionnaires | Not Applicable |
The investigators study the stimulation by the song, material integrating language and music, and having an autobiographical value. The investigators measure the lexical priming capacity of the song, that is, its ability to activate and maintain lexical and semantic representations, which are threatened with alteration in the course of the disease.
This lexical priming effect by song is measured in patients with mild Alzheimer's disease and healthy volunteers during a single test session. In the first phase of the session, participants are exposed to familiar songs, presented in sung, spoken or instrumental form, whose popularity they evaluate. In the second phase, they perform two implicit memory tasks: a trigram completion task and a lexical decision task. These tests measure the facilitation of the processing of words evoked by songs in relation to words unrelated to songs, reflecting a "long-term" memory update of mnemic traces of primed words.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 58 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Other |
| Official Title: | Lexical Priming by Music in Alzheimer's Disease and Healthy Aging |
| Actual Study Start Date : | April 3, 2018 |
| Actual Primary Completion Date : | May 29, 2019 |
| Actual Study Completion Date : | May 29, 2019 |
| Arm | Intervention/treatment |
|---|---|
patient with Alzheimer's Disease
|
Other: Exposure to familiar songs
3 conditions : a) Words and Music (sing condition), b) Words only (spoken condition) and c) Music only (instrumental condition) After each song : rate the popularity of the song on a scale of 1 to 5. Other: Music Experience Questionnaire questions about the past music training Other: Implicit tasks memory 2 tests : a) Completion of trigrams : freely complete the first 3 letters of a word. b) lexical decision : judge whether an audibly presented sound sequence is a word existing in the French language or not. |
healthy volunteer
|
Other: Exposure to familiar songs
3 conditions : a) Words and Music (sing condition), b) Words only (spoken condition) and c) Music only (instrumental condition) After each song : rate the popularity of the song on a scale of 1 to 5. Other: Music Experience Questionnaire questions about the past music training Other: Implicit tasks memory 2 tests : a) Completion of trigrams : freely complete the first 3 letters of a word. b) lexical decision : judge whether an audibly presented sound sequence is a word existing in the French language or not. Other: Questionnaires Mini Mental State Examination, 5 words by Dubois and fluence verbal test |
- Reaction time difference for the treatment of words that have been presented in sing condition in the exposure phase versus words presented in spoken condition. [ Time Frame: Day 1 ]
- Reaction time difference for processing words associated with songs presented by their melody alone versus new words (not presented in the exhibition phase). [ Time Frame: Day 1 ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria for patients :
- Presence of diagnostic criteria for Alzheimer's disease
- Age ≥ 65 years
- MMSE (Mini-mental state Examination) ≥ 20
Exclusion Criteria for patient :
- Unstable clinical presentation or language presentation in the foreground
- Cognitive disorder of etiology different from that of Alzheimer's disease
Inclusion Criteria for volunteers :
- Age ≥ 18 years
- Absence of neurological or psychiatric antecedents
- For those aged 65 or over: MMSE (Mini-mental state Examination) greater than or equal to 27; non-pathological performance against the 5 words of Dubois and the verbal fluency test.
Exclusion Criteria for volunteers :
- Visual or auditory disorders insufficiently corrected
- Oral or written expression in French insufficient to carry out tests
- Consumption of psychotropic drugs not stabilized
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03342326
| France | |
| CHU de Saint Etienne | |
| Saint-Étienne, France, 42055 | |
| Responsible Party: | Centre Hospitalier Universitaire de Saint Etienne |
| ClinicalTrials.gov Identifier: | NCT03342326 |
| Other Study ID Numbers: |
1708117 2017-A02686-47 ( Other Identifier: ANSM ) |
| First Posted: | November 14, 2017 Key Record Dates |
| Last Update Posted: | September 11, 2020 |
| Last Verified: | September 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Lexical priming Healthy Aging |
|
Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Mental Disorders |

